Stock RPRX ROYALTY PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Royalty Pharma plc

Equities

RPRX

GB00BMVP7Y09

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
28 USD -0.39% Intraday chart for Royalty Pharma plc -0.57% -0.32%
04-17 Royalty Pharma Maintains Quarterly Dividend at $0.21 per Share, Payable June 14 to Shareholders of Record May 17 MT
04-17 Royalty Pharma plc Declares Dividend for the Second Quarter of 2024, Payable on June 14, 2024 CI

Chart calendar Royalty Pharma plc

d27fd2dfa92f9e969c037a1da48.msMpLFysg0fWbn6al81qeQxkyEOp0Ar55ifTLd16dJ0.2YdZfj7V4BeVLDrw2ZtaKkgwlxfbuV64jnLrZ5wjNcnN8XBIbM27IpQCSg~8790b207a30aed951b07580615bddf21

Upcoming events on Royalty Pharma plc

08/05/2024 Q1 2024 Earnings Release Pre-market
09/05/2024 13:00 Q1 2024 Earnings Call
13/05/2024 RBC Capital Markets Global Healthcare Conference
06/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Royalty Pharma plc

05/03/2024 15:30 TD Cowen Health Care Conference
15/02/2024 13:00 Q4 2023 Earnings Call
15/02/2024 12:30 Q4 2023 Earnings Release
09/01/2024 17:00 JPMorgan Healthcare Conference
28/11/2023 20:00 Evercore ISI HealthCONx Conference
08/11/2023 13:00 Q3 2023 Earnings Call
08/11/2023 12:00 Q3 2023 Earnings Release
19/10/2023 14:00 Business Update Call
12/09/2023 17:55 Morgan Stanley Global Healthcare Conference
06/09/2023 16:20 Citi BioPharma Conference
08/08/2023 13:00 Q2 2023 Earnings Call
08/08/2023 12:00 Q2 2023 Earnings Release
22/06/2023 14:00 Annual General Meeting
13/06/2023 22:00 Goldman Sachs Global Healthcare Conference
10/05/2023 22:20 BofA Securities Health Care Conference
09/05/2023 13:00 Q1 2023 Earnings Call
09/05/2023 12:00 Q1 2023 Earnings Release
07/03/2023 16:10 Cowen Health Care Conference
16/02/2023 15:40 SVB Securities Global Biopharma Conference
15/02/2023 13:00 FY 2022 Earnings Call

Past dividends on Royalty Pharma plc

14/02/2024 Quarterly 0.21 USD
15/11/2023 Quarterly 0.2 USD
16/08/2023 Quarterly 0.2 USD
17/05/2023 Quarterly 0.2 USD
14/02/2023 Quarterly 0.2 USD
16/11/2022 Quarterly 0.19 USD
17/08/2022 Quarterly 0.19 USD
18/05/2022 Quarterly 0.19 USD
16/02/2022 Quarterly 0.19 USD
17/11/2021 Quarterly 0.17 USD

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 122
1 961
8.2%		2 289
2 127
7.6%		2 237
2 856
-21.69%		2 355
2 978
-20.92%
2 659

EBITDA
Million USD		Released
Forecast
Spread 		1 621
1 616
0.34%		1 944
1 933
0.56%		2 566
2 554
0.45%		2 806
2 734
2.62%
2 483

EBIT
Million USD		Released
Forecast
Spread 		1 598
1 628
-1.86%		1 921
1 899
1.15%		2 560
1 953
31.08%		2 806
2 720
3.15%
2 148

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		230
1 793
-87.17%		1 700
635
167.84%
1 321

Net income
Million USD		Released
Forecast
Spread 		975
1 532
-36.37%		620
937
-33.85%		43,0
569
-92.44%		1 135
707
60.5%
1 054

EPS
USD		Released
Forecast
Spread 		1,61
2,56
-37.26%		1,02
1,54
-33.68%		0,07
1,37
-94.83%		2,53
1,58
60.13%
2,35

Announcement Date17/02/2115/02/2215/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		576
543
6%		562
593
-5.22%		536
534
0.39%		573
610
-6.12%		566
1 097
-48.42%		684
630
8.63%		538
537
0.26%		536
618
-13.29%		596
675
-11.64%
695


629


694


663




EBITDA
Million USD		Released
Forecast
Spread 		494
487
1.52%		556
532
4.45%		480
482
-0.34%		548
535
2.48%		983
982
0.14%		1 044
854
22.19%		498
498
-0.08%		582
603
-3.37%		682
636
7.16%
638


590


648


605


701

EBIT
Million USD		Released
Forecast
Spread 		488
500
-2.31%		550
529
3.89%		480
481
-0.15%		548
482
13.79%		983
796
23.44%		1 044
577
80.87%		498
487
2.24%		582
567
2.72%		682
630
8.27%
541


464


481


561




Net income
Million USD		Released
Forecast
Spread 		8,00
300
-97.33%		52,0
335
-84.47%		305
289
5.45%		143
199
-27.97%		-456
-60,9
-648.96%








494
-170
389.84%
240


-6,24


46,9


484




EPS
USD		Released
Forecast
Spread 		0,01
0,49
-97.31%		0,09
0,80
-89.22%		0,50
0,70
-28.21%		0,24
0,46
-48.7%		-0,75
-0,14
-436.6%








1,10
-0,38
389.47%
0,54


-0,01


0,10


1,08




Announcement Date15/02/2205/05/2204/08/2208/11/2215/02/2309/05/2308/08/2308/11/2315/02/24-----

Upcoming sector events for Royalty Pharma plc

28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
28/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
28/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Royalty Pharma plc

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RPRX Stock
  4. Calendar Royalty Pharma plc